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Forebrain cholinergic neurons play important roles as striatal local
circuit neurons and basal telencephalic projection neurons. The
genetic mechanisms that control development of these neurons
suggest that most of them are derived from the basal telenceph-
alon where Lhx8, a LIM-homeobox gene, is expressed. Here we
report that mice with a null mutation of Lhx8 are deficient in the
development of forebrain cholinergic neurons. Lhx8 mutants lack
the nucleus basalis, a major source of the cholinergic input to the
cerebral cortex. In addition, the number of cholinergic neurons is
reduced in several other areas of the subcortical forebrain in Lhx8
mutants, including the caudate-putamen, medial septal nucleus,
nucleus of the diagonal band, and magnocellular preoptic nucleus.
Although cholinergic neurons are not formed, initial steps in their
specification appear to be preserved, as indicated by a presence of
cells expressing a truncated Lhx8 mRNA and mRNA of the ho-
meobox gene Gbx1. These results provide genetic evidence sup-
porting an important role for Lhx8 in development of cholinergic
neurons in the forebrain.
The mammalian forebrain contains two general types ofcholinergic neurons. One group is composed of local circuit
neurons, such as the cholinergic interneurons of the striatum (1).
These neurons play an important role in the regulation of
locomotor behavior through their modulation of -aminobutyric
acid (GABA)ergic projection neurons in the striatum (2). The
other group consists of projection neurons whose cell bodies can
be found in a series of nuclei in the subcortical telencephalon,
including the medial septum (also designated as Ch1 cholinergic
group by Mesulam et al., ref. 3), the vertical and horizontal limbs
of the nucleus of the diagonal band (designated as Ch2 and Ch3,
respectively; ref. 3), and the basal magnocellular complex (des-
ignated as Ch4; ref. 3), which comprises cholinergic neurons
scattered through the magnocellular preoptic nucleus, substantia
innominata, ventral pallidum, and nucleus basalis. The axonal
projections of these neurons provide the cerebral cortex and
hippocampus with their principal cholinergic input (3–6), which
has a critical role in cognitive functions (for reviews, see refs. 7
and 8). Accordingly, abnormalities of the cholinergic projection
neurons in the basal forebrain are implicated in neurodegen-
erative disorders such as Alzheimer’s disease (9, 10).
The genetic and developmental mechanisms that control the
formation of forebrain cholinergic neurons are just beginning to
be elucidated. The vast majority of forebrain cholinergic neurons
derive from a region of the subcortical telencephalon that
expresses the Nkx2-1 homeobox gene (11, 12). This region
contains different progenitor zones, including the medial gan-
glionic eminence (MGE), anterior entopeduncular area and
preoptic area (POa) (13). It has been proposed that these
progenitor domains contribute projection neurons to the globus
pallidus, ventral pallidum, nucleus of the diagonal band, and
parts of the septum and amygdala, regions that generically are
known as the basal telencephalon. In addition, a substantial
fraction of striatal, cortical, and hippocampal interneurons
originates from these progenitor zones and migrate tangentially
to reach their final destinations (reviewed in ref. 14).
Nkx2-1 appears to specify the development of the basal
telencephalon by repressing more dorsally expressed transcrip-
tion factors (e.g., Pax6) and by positively regulating the expres-
sion of other transcription factors such as the LIM-homeodo-
main proteins Lhx6 and Lhx8 (11) [Lhx8 is also known as L3 (15)
and Lhx7 (16)]. At birth, Nkx2-1 mutants lack all cholinergic
neurons in the subpallium, including striatal interneurons and
basal forebrain projection neurons, and such defects are asso-
ciated with a complete loss of Lhx6 and Lhx8 expression in the
developing telencephalon (11, 12). Interestingly, although Lhx6
expression appears to be associated with GABAergic neurons,
Lhx8 expression is coupled to cholinergic neurons (12, 17).
To establish the role of Lhx8 in regulating the development of
cholinergic neurons in the telencephalon, we have analyzed the
development of the basal telencephalon in mutant mice that lack
Lhx8 function (18). Our results demonstrate that Lhx8 is re-
quired for the formation of specific subsets of forebrain cholin-
ergic neurons.
Materials and Methods
Animals and Tissue Preparation. As described in ref. 18, the Lhx8
mutant mice were generated by deleting exons 4–6 of the Lhx8
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Fig. 1. In situ analysis of Lhx8 mRNA expression in the developing mouse
basal forebrain. (A and B) Lhx8 expression in the MGE and POa (PO) of E11.5
(A) and E12.5 (B) mouse embryos. Arrowheads point at labeled cells migrating
from the MGE into the lateral ganglionic eminence (LGE). (C) Detection of
Lhx8 mRNA in a dispersed population of cells in the striatum (pointed by an
arrowhead) in addition to the MGE and POa at E14.5. (D) Expression of Lhx8
mRNA in the caudate-putamen (CP), globus pallidus (GP), and in cells dis-
persed ventral-medial to the globus pallidus (pointed by an arrowhead) at
E16.5. Mx and Md, the maxillary and mandibular processes of the first
branchial arch. (Scale bar in D represents 250 m for all panels.)
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gene that encode part of the first LIM domain, the entire second
LIM domain, and part of the homeodomain of the Lhx8 protein.
About 60% of the Lhx8 homozygous mutants show a complete
cleft of the secondary palate and die soon after birth, whereas
the remaining 40% appear healthy and have a normal lifespan.
For analysis, mouse embryos were isolated from pregnant fe-
males at various stages of development. Noon of the day when
a vaginal plug was identified was designated as embryonic day
(E) 0.5. The embryos were fixed by immersion in 4% parafor-
maldehyde0.1 M phosphate buffer (pH 7.4) overnight at 4°C.
After washes in PBS, the embryos were either dehydrated
through a graded series of ethanol and embedded in paraffin, or
cryoprotected in 30% sucrose and frozen in OCT compound
(Sakura, Torrance, CA). To fix newborn (P0) pups or 6- to
7-week-old mice, animals were anesthetized and perfused tran-
scardially with 4% paraformaldehyde0.1 M phosphate buffer
(pH 7.4). The brains were dissected out, postfixed in the same
fixative overnight at 4°C, and processed with the same proce-
dures used for the embryos.
In Situ Hybridization. In situ hybridization was performed on 5-m
paraffin sections or 10-m frozen sections as described (12, 19).
[33P]- or [35S]UTP-labeled antisense probes were synthesized by
in vitro transcription using vectors containing cDNAs of Gad67,
Gbx2, Islet1 (Isl1), Lhx6, and Lhx8 (12, 18, 20). For analysis of
Gbx1 expression, 20-m frozen sections were hybridized with
digoxigenin-labeled probes synthesized from a vector containing
the Gbx1 coding sequence (M. Frohman, personal communica-
tion) as described (21).
Immunohistochemistry. Immunostaining was performed on
40-m free-floating frozen sections. For immunoperoxidase
labeling, sections were treated with ice-cold PBS containing 10%
methanol and 0.1% hydrogen peroxide to inactivate endogenous
peroxidase. Sections were incubated in PBS containing 2% BSA,
5% normal serum of the species from which the secondary
antibody was derived, and 0.3% (for sections from P0 pups) or
0.4% (for sections from adult mice) Triton X-100. The sections
were then incubated with primary antibodies diluted with PBS
containing 2% normal serum and 0.3% (P0 sections) or 0.4%
(adult sections) Triton X-100 for 40–60 h at 4°C. The antibodies
used and their dilutions are as follows: goat anti-choline acetyl-
transferase (ChAT) (Chemicon), 1:250; rat anti-somatostatin
(Chemicon), 1:100; rabbit anti-calretinin (Chemicon), 1:2,500.
After primary antibody incubation, sections were washed in
PBS0.3% (for P0 sections) or 0.4% (for adult sections) Triton
X-100, incubated with biotinylated secondary antibodies (KPL,
Gaithersburg, MD or Vector Laboratories), and processed with
a Vectastain ABC kit (Vector Laboratories). The sections were
developed by using AEC as a chromogen (Zymed), counter-
stained with hematoxylin, and mounted with Aqua PolyMount
(Polysciences). For labeling of parvalbumin-positive neurons,
sections were stained with a mouse anti-parvalbumin antibody
(Sigma, 1:2,000) by using a histomouse kit (Zymed). TrkA-
positive neurons were labeled with a rabbit anti-TrkA antibody
(generously provided by L. Reichardt, University of California,
San Francisco), as described (11).
Results
Expression of Lhx8 mRNA in the Developing Basal Forebrain. To
provide a context for the phenotypic characterization of Lhx8
mutants, we analyzed the expression of Lhx8 mRNA in the
telencephalon from E11.5 to E16.5 (Fig. 1). In agreement with
previous reports (11–17), Lhx8 expression between E11.5 and
E12.5 is largely restricted to the basal telencephalon, including
the MGE, and POa (Fig. 1 A and B). Lhx8 mRNA was found in
Fig. 2. Embryonic defects in the organization of the basal forebrain of Lhx8
mutants. Adjacent coronal sections through the telencephalon of E13.5 em-
bryos showing expression of Lhx8 (A and B), Lhx6 (C and D), Isl1 (E and F), and
Gbx2 (G and H) mRNA in wild-type controls (A, C, E, and G) and Lhx8 mutants
(B,D, F, andH). (C andD) Arrowheads point at labeled cells migrating from the
basal telencephalon to the cortex. (E–H) Arrows and arrowheads indicate the
proliferative and mantle regions of the preoptic area, respectively. Note that
the expression of Isl1 andGbx2 is reduced in these regions in Lhx8mutants. H,
hippocampus; LGE, lateral ganglionic eminence; MGE, medial ganglionic
eminence; NC, neocortex; PO, preoptic area; St, striatum; Th, thalamus. (Scale
bar in B represents 500 m for all panels.)
Fig. 3. Defects in development of telencephalic cholinergic neurons in P0 Lhx8 mutants (B, D, F, H, and J) as compared with wild-type controls (A, C, E, G, and
I). (A–F) Anti-ChAT staining of the caudate-putamen (A and B), nucleus basalis (C and D), and magnocellular preoptic nucleus (E and F). (G and H) Anti-TrkA
staining of the magnocellular preoptic nucleus. Note that the number of labeled cells is reduced in Lhx8 mutants. (I and J) In situ analysis showing that the
expression ofGbx1mRNA was maintained in the nucleus basalis and magnocellular preoptic nucleus in Lhx8mutants. CP, caudate-putamen; GP, globus pallidus;
MPN, magnocellular preoptic nucleus; NB, nucleus basalis. (Scale bar in J represents 180 m for all panels.)
9006  www.pnas.orgcgidoi10.1073pnas.1537759100 Zhao et al.
scattered cells in the ventricular zone and in most cells through-
out the subventricular and mantle zones. In addition, a thin layer
of expression was found to extend into the mantle zone of the
lateral ganglionic eminence. By E14.5, strong expression re-
mained throughout the subventricular zone of the basal telen-
cephalon, particularly in the POa (Fig. 1C). Abundant cells were
also found in the basal telencephalic mantle zone, and a few
Lhx8-positive cells were present in the striatum (Fig. 1C). At
E16.5, in addition to its expression in the basal telencephalic
subventricular zone, strong expression was found in the globus
pallidus as well as in scattered cells throughout the POa, ventral
pallidum, and striatum (Fig. 1D). These observations, together
with results from the previous studies (11, 12, 17), suggest that
Lhx8 is broadly expressed in the developing basal telencephalon
and therefore could potentially regulate the development of both
GABAergic and cholinergic neurons derived from this region.
Early Molecular Defects in the Development of the Basal Telenceph-
alon in Lhx8 Mutants. To begin to assess the role of Lhx8 in the
generation of specific neuronal populations in the basal telen-
cephalon, we analyzed the expression of markers implicated in
the development of cells derived from the basal telencephalon at
E13.5. First, we studied expression from the mutant Lhx8 locus
because the mutation did not delete the promoter and some of
the exonic sequences of Lhx8 (18). Truncated Lhx8 transcripts
were found in roughly a normal pattern in Lhx8 mutants,
although their level of expression was reduced (Fig. 2 A and B).
This observation suggests that the deletion did not remove an
essential enhancersilencer domain from the Lhx8 locus and that
at least some of the cells specified to express Lhx8 are produced
in the absence of Lhx8.
The initial expression of Lhx8 in the basal telencephalon is
very similar to that of Lhx6 (11, 16) (Figs. 1 and 2 A and C).
Despite this, loss of functional Lhx8 did not affect Lhx6 expres-
sion at E13.5. As in control mice, Lhx6 mRNA was expressed in
cells throughout the developing basal telencephalon as well as in
cells tangentially migrating to the cerebral cortex in Lhx8
mutants (Fig. 2 C and D). This observation suggests that Lhx8 is
not required for the development of tangentially migrating
GABAergic neurons. Accordingly, analysis of expression of
Gad67 mRNA, a marker specific for GABAergic neurons,
revealed no perceptible changes in Lhx8 mutants (data not
shown), reinforcing the notion that Lhx8 does not play a major
role in the early development of GABAergic neurons derived
from the basal telencephalon.
We next assessed the expression of Isl1, a LIM-homeobox gene
that regulates the development of cholinergic neurons in the
spinal cord (22) and that is expressed in telencephalic cholinergic
neurons at late embryonic stages (23). In addition to its prom-
inent expression in the developing striatum, Isl1 mRNA was
found in progenitor cells of the POa and in adjacent mantle areas
(Fig. 2E). In Lhx8 mutants, expression of Isl1 was roughly
normal in the striatal mantle, but it was reduced in the POa and
in the superficial mantle zone of the MGE (i.e., the developing
ventral pallidum and substantia innominata; Fig. 2F). The
developing ventral pallidum also expresses Gbx1, a homeobox
gene found in basal telencephalic cholinergic neurons at late
embryonic stages (17). Expression of Gbx1, however, was
roughly normal in Lhx8 mutants (data not shown). In contrast,
expression of Gbx2 (20), a homeobox gene closely related to
Gbx1, was reduced in Lhx8 mutants (Fig. 2 G and H). Thus, the
reduction in Isl1 expression in the POa suggests a possible defect
in the development of cholinergic neurons, whereas the normal
expression of Lhx6 and Gad67 implies that GABAergic neurons
are not affected by the Lhx8 mutation. These hypotheses were
examined by analyzing Lhx8 mutants at P0 and in adulthood.
Reduction of Cholinergic Neurons in the Telencephalon of P0 Lhx8
Mutants. To establish whether Lhx8 regulates the development of
cholinergic neurons in the telencephalon, we studied the expres-
sion of ChAT, a key enzyme in the synthesis of acetylcholine, at
Fig. 4. Anti-ChAT staining showing a reduction in the number of cholinergic
interneurons in the caudate-putamen of adult Lhx8mutants (B,D, F, andH) as
compared with wild-type controls (A, C, E, and G). (A and B) Sections from a
rostral level. (C and D) Enlargement of the outlined areas in A and B, respec-
tively. (E and F) Sections from a middle level. (G and H) Sections from a caudal
level. Arrowheads in A, B, and E–H indicate the somas of ChAT neurons.
Arrowheads in C point at ChAT neuropil, which is reduced in Lhx8 mutants.
ac, anterior commissure; CP, caudate-putamen; GP, globus pallidus; NaS,
nucleus accumbens, shell; S, septum. (Scale bar in H represents 300 m for A,
B, and E–H, and 60 m for C and D.)
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P0, when it is first detectable in telencephalic cholinergic neu-
rons. Compared with wild-type controls, Lhx8 mutants con-
tained far less ChAT-positive (ChAT) cells in the striatum
(Fig. 3 A and B) and in the basal magnocellular complex (Ch4),
including the nucleus basalis (Fig. 3 C and D) and the magno-
cellular preoptic nucleus (Fig. 3 E and F). In addition, the
number of cells positive for the nerve growth factor receptor
TrkA, another marker of the basal forebrain cholinergic neu-
rons, was also diminished in Lhx8 mutants (Fig. 3 G and H, and
data not shown). In contrast, the expression of Gbx1 was roughly
normal in the basal telencephalon of Lhx8 mutants (Fig. 3 I and
J), suggesting that basal telencephalic cholinergic neurons are
born but fail to differentiate properly in the mutants. To
determine whether the reduction in expression of the cholinergic
markers reflects a developmental delay or a definitive loss of
cholinergic neurons, we next studied adult Lhx8 mutants.
Reduction of Cholinergic Interneurons in the Telencephalon of Adult
Lhx8 Mutants. Immunohistochemical analysis of the distribution
of ChAT neurons in the brain of adult mice revealed that the
number of cholinergic interneurons was reduced severely
throughout the rostral-caudal axis of the caudate-putamen in
Lhx8 mutants (Fig. 4 B, D, F, and H) as compared with wild-type
controls (Fig. 4 A, C, E, and G). For quantification, the neurons
labeled in the caudate-putamen were counted on three serial
sections (with a distance of 200 m from each other) in a region
anterior to the crossover of the anterior commissure. Lhx8
mutants were found to contain only 25% of ChAT cells that
were normally present in the controls (average number of
neurons  standard deviation: controls: 843  151, n  4; Lhx8
mutants: 218  112, n  4; t test, P  0.0008). Consistent with
the reduction in number of ChAT cell bodies, the density of the
ChAT neuropil formed by the dendrites and axons of the
cholinergic interneurons in the dorsal striatum was also reduced
in the mutants (Fig. 4). In contrast to the dorsal striatum, the
number of ChAT cells in the ventral striatum, including the
nucleus accumbens and the olfactory tubercle, seemed not to be
affected in Lhx8 mutants (Fig. 4 A and B and data not shown).
In addition to cholinergic interneurons, the striatum contains
three types of GABAergic interneurons (24) that can be distin-
guished by their expression of different markers such as parv-
albumin, somatostatin and calretinin, respectively. Staining for
these markers revealed that all these three types of GABAergic
striatal interneurons were normally present in Lhx8 mutants (see
Fig. 7, which is published as supporting information on the PNAS
web site, www.pnas.org). Thus, loss of Lhx8 causes a permanent
deficit of cholinergic interneurons in the dorsal striatum, but
does not affect the development of GABAergic interneurons.
Reduction of Cholinergic Projection Neurons in the Telencephalon of
Adult Lhx8 Mutants. ChAT immunostaining also revealed a severe
reduction in the number of cholinergic projection neurons in the
basal telencephalon of adult Lhx8 mutants (Fig. 5). The nucleus
basalis (Ch4) was almost entirely devoid of ChAT neurons in
Lhx8 mutants (Fig. 5 A and B). The number of ChAT neurons
in the magnocellular preoptic nucleus (Ch4) was also drastically
reduced in the mutants as compared with wild-type controls
(Fig. 5 C and D). Because these cholinergic neurons provide
major cholinergic input to the cortex, consequentially the cho-
linergic innervation of the cerebral cortex was diminished in the
mutants (Fig. 5 E and F). The cholinergic input to the hippocam-
pus is largely derived from the septum (Ch1) and the nucleus of
the diagonal band (Ch2 and 3). In Lhx8 mutants, the number of
ChAT neurons in some of those regions was also reduced as
compared with that in wild-type controls (Fig. 5 G and H). By
counting ChAT cells on three selected sections that represent
the anterior, middle, and posterior levels of the septum, it was
found that there was a 56% reduction in the number of these
Fig. 5. Anti-ChAT staining showing a reduction in number of the telencephalic cholinergic projection neurons in adult Lhx8 mutants (B, D, F, H, J, and L) as
compared with wild-type controls (A, C, E, G, I, and K). (A and B) Absence of ChAT neurons in the nucleus basalis. Arrowheads in A point at ChAT neurons
of the nucleus basalis in the control, which are missing in the mutant (B). (C andD) Reduction in number of ChATneurons in the magnocellular preoptic nucleus
(MPN). (E and F) Reduction of ChAT nerve fibers in the neocortex (NC). Arrowheads in E point at ChAT fibers in the control, which are largely missing in the
mutant (F). (G and H) Reduction in number of ChAT neurons in the medial septal nucleus (MS) and the vertical limb of the nucleus of the diagonal band (VDb).
(I–L) Reduction of ChAT neuropil in the hippocampus. K and L are enlargement of the areas outlined in I and J, respectively. Arrowheads in K point at ChAT
fibers in the controls, which are reduced in the mutants. ac, anterior commissure; CA3, CA3 region of the Ammon’s horn; CP, caudate-putamen; DG, dentate gyrus;
GP, globus pallidus; NaS, nucleus accumbens, shell. (Scale bar in A represents 500 m for A–D and G–J, and 200 m for E, F, K, and L.)
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neurons in the medial septal nucleus (Ch1) and the vertical limb
of the nucleus of the diagonal band (Ch2) (average number of
neurons  standard deviation: controls: 347  92, n  3; Lhx8
mutants, 151  72, n  4; t test, P  0.04). Consistent with
such a reduction in ChAT neurons, the cholinergic projection
to the hippocampus was significantly reduced in the mutants
(Fig. 5 I–L).
Discussion
Herein we demonstrate that loss of Lhx8 function, via a targeted
mutation in the mouse, blocks the formation of most cholinergic
neurons in the mouse forebrain (see Fig. 6 for summary). Thus,
LIM-homeobox genes have a central role in regulating cholin-
ergic development throughout the central nervous system, as
Isl1, Lhx1, Lhx3, and Lhx4 have been shown to function in
controlling motor neuron development in the hindbrain and
spinal cord (22, 25, 26). Given that spinal cord cholinergic
neurons require multiple LIM-homeobox genes for their devel-
opment, and that loss of Lhx8 does not prevent the development
of all telencephalic cholinergic neurons, it is likely that Lhx8 is
not the only LIM-homeobox gene that is required in generating
telencephalic cholinergic neurons. Likely candidates include
Lhx6 and Isl1, because they are also expressed in the basal
telencephalon (11, 12, 16, 23). Presently, no information is
available on Lhx6 function and, unfortunately, Isl1 mutants die
before their ability to generate telencephalic cholinergic neurons
can be established (22). On the other hand, it is likely that Isl1
cooperates with Lhx8 in the development of telencephalic
cholinergic neurons. Isl1 is expressed in these neurons at birth
(23). In addition, Isl1 is known to form complexes with products
of other LIM-homeobox genes (e.g., Lhx3) that are implicated in
controlling whether a differentiating progenitor cell in the spinal
cord generates a motor neuron (cholinergic) or a V2 interneuron
(GABAergic) (27). It remains to be determined whether Isl1 can
complex with Lhx8.
Lhx8 is required to generate multiple types of telencephalic
cholinergic neurons, including hippocampal and cortical projec-
tion neurons in the septum and nucleus basalis, respectively, and
local circuit neurons in the striatum. Thus, Lhx8 is proximal in
the genetic hierarchy that controls telencephalic cholinergic
development. Although Lhx8 is required to generate most of the
cholinergic neurons in this region, at least some subsets are
produced in its absence. For example, the cholinergic interneu-
rons in the ventral striatum (e.g., the nucleus accumbens) (Fig.
4) and the parvocellular component of the cholinergic magno-
cellular preoptic nucleus (Fig. 5) are still present in Lhx8
mutants. Future studies are needed to identify the genes that
specify subtypes of cholinergic projection and local circuit
neurons.
Lhx8 is expressed in progenitor cells in the subventricular
zone, and is maintained in postmitotic neurons (Fig. 1) (11, 12,
17). Thus, Lhx8 may function at multiple developmental stages
and perhaps in mature cholinergic neurons. Lack of Lhx8 protein
does not prevent the generation of cells that expressLhx8mRNA
(Fig. 2), although these cells fail to differentiate into cholinergic
neurons. The fact that expression of Gbx1, which is normally
found in cholinergic neurons in the nucleus basalis (17), is
maintained in Lhx8 mutants reinforces the notion that Lhx8 is
required for the acquisition of the cholinergic phenotype (e.g.,
ChAT and TrkA expression) rather than for the initial specifi-
cation of these neurons.
Insights into some of the genetic pathways that regulate
telencephalic cholinergic development are now available. Early
steps in the program begin with specification of the anterior
telencephalon at neural plate stages; this region includes the
anlage of the basal telencephalon (30), and appears to require
Six3 and Vax1 (31, 32). Sonic hedgehog and nodal type trans-
forming growth factor (TGF)- signaling are important for
induction of Nkx2-1 expression in the telencephalon (33), which
begins soon after neural tube closure and defines the basal
telencephalic anlage (34, 35). Nkx2–1 is required for telence-
phalic expression of Sonic hedgehog, Lhx6, and Lhx8 (11, 12).
Lhx8 controls cholinergic development perhaps through regu-
lating Isl1 and Gbx2 expression (Fig. 2). Dlx12 and Mash1,
though not directly regulatingLhx8, participate in controlling the
number of cholinergic neurons that are formed in the telen-
Fig. 6. Schemas illustrating the origin and migration of cholinergic neurons
derived from the basal telencephalon and the genes that are involved in their
specification and differentiation. (A) The schematic of transversal hemi-
sections through the embryonic telencephalon summarizes the expression of
Lhx8. Lhx8 neurons differentiate as interneurons in the striatum or as
projection neurons in the basal telencephalon (Ch1–Ch4 cholinergic groups).
(B) Model describing some of the genes that regulate production of cholin-
ergic neurons in the telencephalon. Nkx2-1 regulates production of cells that
express Lhx8 (11), which is necessary for the differentiation of most cholinergic
neurons in the basal telencephalon (this study).Nkx2-1 is also required for the
specification of GABAergic neurons (11), and some cholinergic neurons in
the telencephalon develop in the absence of Lhx8 function (dashed line).
In the striatum, cholinergic interneurons express Nkx2-1, Lhx8, and Isl1. In
addition to Nkx2-1 and Lhx8, cholinergic projection neurons in the basal
telencephalon express Isl1 and Gbx1. Whereas the Gbx1 expression is main-
tained, the Isl1 expression is reduced in Lhx8 mutants. The expression of Gbx2
is also reduced in the mantle zone of the MGE in Lhx8mutants. AlthoughGbx2
is not expressed in the mature cholinergic neurons (17), its expression in the
MGE suggests that it may be expressed in the progenitors of the cholinergic
neurons. (C and D) Schemas illustrating the distribution of ChAT cells in the
adult telencephalon of control and Lhx8 mutant mice. Lhx8 mutation prefer-
entially blocks the differentiation of cholinergic interneurons in the striatum
and large projection neurons in the basal forebrain. In Lhx8 mutants, small
ChAT cells are still present in the cortex and basal forebrain. Expression of
Gbx1 in the basal forebrain of Lhx8mutants suggests that cholinergic cells are
born in Lhx8 mutants, but they fail to differentiate properly (i.e., lack ChAT
and TrkA expression). AEP, anterior entopeduncular region; BMC, basal mag-
nocellular complex; Ch1–Ch4, Ch1–Ch4 cholinergic cell groups; CP, caudate-
putamen; GP, globus pallidus; H, hippocampus; HLDB, horizontal limb of
diagonal band; LGE, lateral ganglionic eminence; LOT, lateral olfactory tract;
MGE, medial ganglionic eminence; MS, medial septal nucleus; NA, nucleus
accumbens; NC, neocortex; St, striatum; VLDB, vertical limb of diagonal band.
Zhao et al. PNAS  July 22, 2003  vol. 100  no. 15  9009
N
EU
RO
SC
IE
N
CE
cephalon by regulating the differentiation of late and early-born
neurons, respectively (12). Because cholinergic neurons are
among the earliest born neurons in the telencephalon (36, 37),
loss of Mash1 affects the differentiation of cholinergic neurons
more severely than mutation of Dlx12. In addition, signaling
molecules of the bone morphogenetic protein family also regu-
late the differentiation of the telencephalic cholinergic neurons
(38). Finally, later steps in cholinergic differentiation and sur-
vival are regulated by galanin (39, 40) and nerve growth factor
(41, 42). Future studies are required to establish whether Lhx8
controls the maturation and function of telencephalic cholin-
ergic neurons, as these cells have critical roles in regulating
cognitive and motor functions, and they are among the first
neurons to degenerate in Alzheimer’s disease.
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